Allergy Desensitization: From Noon 1911 to Modern SCIT
Allergy desensitization is the historically correct term for subcutaneous allergen immunotherapy (SCIT) — the procedure Noon introduced in 1911 and the field used through most of the 20th century. The AAAAI/ACAAI shifted to 'allergen immunotherapy' as the preferred term in the 2011 Practice Parameter, but the procedure is unchanged: a 3-to-5-year course of escalating allergen-extract injections producing immune tolerance with a Cochrane symptom SMD of -0.73 across 51 RCTs (Calderón 2007).
6 peer-reviewed sources
Allergy desensitization is the older clinical term for subcutaneous allergen immunotherapy (SCIT) — the same procedure now called allergen immunotherapy in current AAAAI/ACAAI guidelines, with identical mechanisms and evidence base.
The essentials
Allergy desensitization names a procedure that has not changed since Leonard Noon first injected timothy-grass-pollen extract into hay-fever patients at St Mary's Hospital, Paddington, and published his results in Lancet 1911;1:1572-1573. What Noon called 'prophylactic inoculation' or 'desensitization,' the 2011 AAAAI/ACAAI/JCAAI Practice Parameter Third Update (Cox L, Nelson H, Lockey R et al., J Allergy Clin Immunol 2011;127(1 Suppl):S1-S55, DOI 10.1016/j.jaci.2010.09.034) calls 'subcutaneous immunotherapy (SCIT).' The mechanism, the evidence, and the clinical standard are the same.
The terminology shift matters practically. In modern clinical literature, 'desensitization' more often denotes acute drug-desensitization protocols — rapid 12-step doubling-dose regimens over 4-6 hours, used for penicillin, aspirin (AERD), and platinum-based chemotherapy in IgE-sensitized patients. This is mechanistically distinct from chronic allergen desensitization (SCIT/SLIT over years). Patients searching for 'allergy desensitization' are almost always looking for the chronic allergen version.
Curex's at-home IgE blood test with allergist review confirms which allergens are clinically relevant before a desensitization plan — SCIT or SLIT — is built, anchoring the dose-escalation schedule to the actual sensitization profile.
Chronic allergen desensitization follows a standardized dose-escalation schedule per Cox 2011: conventional build-up involves 24-28 weekly injections escalating from approximately 0.05 mL of the most dilute vial to 0.5 mL of maintenance concentrate. Cluster build-up (2-4 injections per visit) compresses this to 4-8 weeks (Tabar AI et al., JACI 2005;116:109-118). Rush build-up completes in 1-3 days (Bernstein DI et al., JACI 2008). Maintenance continues every 2-4 weeks for 3-5 years.
Long-term efficacy of allergen desensitization is well established. Cochrane meta-analysis (Calderón MA et al., 2007, DOI 10.1002/14651858.CD001936.pub2) across 51 RCTs and 2,871 patients found a symptom SMD of -0.73 and a medication SMD of -0.57. Durham SR et al. (N Engl J Med 1999;341:468-475) demonstrated sustained remission after a 3-4 year grass-pollen course ended. In children, Jacobsen L et al. (Allergy 2007, PAT 10-year follow-up) found SCIT-treated children had an adjusted OR of 4.6 (95% CI 1.5-13.7) for asthma prevention.
How allergy shots retrain your immune system
The mechanism of allergy desensitization is the same regardless of whether the historical or modern term is used: induction of allergen-specific regulatory T cells (Tregs), downregulation of Th2 cytokines (IL-4, IL-5, IL-13), and induction of IgG4 blocking antibodies that compete with IgE for allergen binding (Cox 2011 §Mechanism). This immunological reprogramming explains why the clinical benefit persists after the desensitization course ends.
IgE Sensitization Confirmed Before Desensitization
Allergen desensitization requires confirmed IgE sensitization before initiation per Cox 2011. Only sensitizations confirmed by skin prick test or specific IgE blood test are included in the desensitization extract.
Dose Escalation Induces Treg Expansion
Weekly escalating injections from 0.05 mL of the most dilute vial to 0.5 mL of maintenance concentrate induce FOXP3+ CD25+ Tregs and IL-10-producing Tr1 cells. These cells produce anti-inflammatory cytokines that suppress Th2 responses.
IgG4 Blocking Antibodies Prevent Mast Cell Activation
Allergen-specific IgG4 rises 10-100-fold above pre-treatment levels during the desensitization course. These blocking antibodies compete with IgE at the allergen-binding site, preventing the mast cell degranulation cascade that produces allergy symptoms.
Ready to skip the surprise bills?
See if at-home allergy shots fit your allergies — a 2-minute quiz, designed by board-certified allergists, with flat monthly pricing and no clinic visits.
- 4.8/5Patient rating
- $129/moFlat pricing
- 50K+Patients treated
- HSA/FSAEligible
Treatment timeline — phase by phase
The allergy desensitization timeline follows the same three phases as SCIT under its modern name.
Conventional build-up: 24-28 weekly injections to maintenance. Cluster (Tabar 2005 JACI): maintenance in 4-8 weeks with 2-4 injections per visit. Rush (Bernstein 2008 JACI): 1-3 days with pre-medication. Each injection followed by mandatory 30-minute observation.
Maintenance injections continue every 2-4 weeks for 3-5 years, with 30-minute observation at each visit. Adherence data: 43.9% of initiators reach maintenance (Tkacz JP et al., Curr Med Res Opin 2021, DOI 10.1080/03007995.2021.1903848).
Durham SR et al. (N Engl J Med 1999;341:468-475) demonstrated sustained clinical remission after a completed 3-4 year grass-pollen desensitization course. Pediatric asthma prevention documented at 10-year follow-up (Jacobsen 2007 PAT, OR 4.6).
Same proven results. No clinic visits.
Curex's at-home allergy shots deliver the same allergen desensitization as clinic SCIT — for a flat $129/month, with no clinic visits and no facility fees.
See if at-home shots are right for youFrequently asked questions
What is allergy desensitization?
Allergy desensitization is the historical term for subcutaneous allergen immunotherapy (SCIT) — a 3-to-5-year course of escalating allergen extract injections that induce immune tolerance to specific allergens. Leonard Noon first described the procedure in Lancet 1911, calling it 'prophylactic inoculation against hay fever.' The AAAAI/ACAAI 2011 Practice Parameter (Cox L, Nelson H, Lockey R et al., J Allergy Clin Immunol 2011;127(1 Suppl):S1-S55) uses 'allergen immunotherapy' as the preferred term, but both names refer to the same procedure: injection of escalating allergen doses under the skin to shift the immune response from Th2-driven inflammation to allergen-specific regulatory T-cell tolerance.
Is allergy desensitization the same as allergy immunotherapy?
Yes — allergy desensitization and allergen immunotherapy are synonyms for the same procedure. The terminology evolved: Noon (1911) used 'desensitization'; the WHO 1998 position paper (Bousquet J, Lockey R, Malling HJ, JACI 1998;102:558-562, PMID 9802362) endorsed 'allergen vaccine'; the AAAAI/ACAAI 2011 Practice Parameter settled on 'allergen immunotherapy.' The mechanism (Treg induction, IgG4 blocking antibodies, Th2 downregulation), the schedule (build-up plus 3-5 years of maintenance), and the clinical outcomes (Cochrane SMD -0.73; Durham 1999 NEJM durable remission) are identical regardless of the name used.
How long does allergy desensitization take?
Chronic allergen desensitization (SCIT) requires 3-5 years total: approximately 24-28 weekly build-up visits over 3-6 months, followed by maintenance injections every 2-4 weeks for 3-5 years — totaling approximately 60-80+ clinic visits. Cluster protocols compress build-up to 4-8 weeks (Tabar AI et al., JACI 2005;116:109-118) at a higher per-injection systemic-reaction risk. Disease-modifying benefits typically become noticeable within 3-6 months of reaching maintenance and persist for 3-12 years after the course ends (Durham 1999 NEJM). This is fundamentally different from acute drug desensitization (e.g., penicillin), which is completed in 4-6 hours at a hospital.
Is allergy desensitization safe?
Allergen desensitization (SCIT) has one of the strongest safety records in clinical medicine — one confirmed fatality per 23.3 million US injection visits (2008-2012) per Epstein TG et al. (PMID 24607043). Systemic reactions occur in approximately 0.1% of injection visits. That safety record was built around in-clinic administration with epinephrine available and a post-injection observation period per Cox 2011 Summary Statement 32. At-home SCIT programs replicate those same pillars outside the clinic: Curex confirms a prescribed epinephrine auto-injector is on hand before the first injection, supervises the first dose and every dose escalation live over Zoom, and maintains board-certified allergist oversight throughout. The primary risk factors for serious reactions are uncontrolled asthma, prior systemic reactions, and dosing during peak allergen season — patient eligibility screening addresses these before the program begins. If you experience throat tightness, difficulty breathing, generalized hives, or lightheadedness after an injection, use your prescribed epinephrine auto-injector now and call 911.
What is the difference between allergy desensitization and drug desensitization?
Allergy desensitization (SCIT) is a chronic allergen immunotherapy course lasting 3-5 years — it induces lasting immune tolerance to environmental or venom allergens. Drug desensitization protocols (e.g., penicillin desensitization, aspirin desensitization for AERD, chemotherapy drug desensitization) are acute procedures completed in 4-6 hours using 12-step doubling-dose regimens. Both share the dose-escalation principle, but the timescale, target antigen, and clinical goal are fundamentally different. Patients researching 'allergy desensitization' for hay fever or dust-mite allergy are asking about the chronic SCIT course — not an acute drug protocol.
Does allergy desensitization prevent asthma?
Yes — allergen desensitization (SCIT) has demonstrated asthma-prevention benefit in children. Jacobsen L et al. (Allergy 2007;62:943-948, PAT 10-year follow-up) found SCIT-treated children had an adjusted OR of 4.6 (95% CI 1.5-13.7) for asthma prevention versus controls. Möller C et al. (J Allergy Clin Immunol 2002) confirmed the preventive effect with sublingual immunotherapy in allergic children as well. No pharmacotherapy (antihistamines, intranasal steroids) has demonstrated asthma prevention from allergic rhinitis. This preventive effect is one of the strongest clinical arguments for initiating allergen desensitization in allergic children before asthma develops.
Related Articles
Allergy Infusion: Xolair vs SCIT Disambiguation | Curex
Allergy infusion usually means Xolair (omalizumab) — a subcutaneous injection, NOT an IV. There is no IV allergy immunotherapy product on the US market. SCIT is a small SC injection.
Read moreAllergy Shots: The Complete Patient Guide to SCIT | Curex
Allergy shots (SCIT) are the only FDA-recognized disease-modifying allergy treatment. Learn who qualifies, how they work, and what alternatives exist.
Read moreMold Allergy Shots: Evidence & Limits | Curex Guide
Mold SCIT has one well-controlled RCT allergen — Alternaria (Kuna 2011: 63.5% reduction). Cladosporium, Aspergillus, Stachybotrys lack RCT support. Full honest guide.
Read moreAllergy Injection Site: Anatomy & Technique | Curex
SCIT injections go subcutaneously into the posterolateral upper outer arm, alternating arms each visit. 26-27G needle. Not intramuscular. Not intradermal.
Read moreCat Allergy Shots for Humans | Curex SCIT Guide
Cat allergy shots use FDA-standardized Fel d 1 extract for ~72% symptom relief. RCT evidence, schedule, plus at-home SCIT from Curex at $129/mo.
Read moreAllergy Shot Treatment Program Guide | Curex
Allergy shot treatment is a 3-5 year SCIT program. Cochrane 51 RCTs: SMD -0.73. Durham 1999 NEJM: remission persists after stopping. Real-world: only 43.9% reach maintenance.
Read moreGet your allergy shots — without the clinic.
Curex's flat $129/month covers end-to-end at-home immunotherapy — a personalized serum compounded to USP <797> sterile standards, board-certified allergist oversight, and one weekly injection you give yourself at home. No clinic visits, no facility fees. HSA/FSA eligible.
$129/mo flat · No facility fees · HSA/FSA eligible · Cancel anytime
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.